Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09441 | 31749300 | Liver Int | Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease. | 2019 | Details |
| A09442 | 31748681 | Lab Invest | Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver. | 2019 | Details |
| A09443 | 31746883 | Food Funct | Artemisia sphaerocephala Krasch polysaccharide prevents hepatic steatosis in high fructose-fed mice associated with changes in the gut microbiota. | 2019 | Details |
| A09444 | 31746482 | Aliment Pharmacol Ther | Systematic review: chronic viral hepatitis and metabolic derangement. | 2019 | Details |
| A09445 | 31746151 | Adv Healthc Mater | In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells. | 2019 | Details |
| A09446 | 31745210 | Lab Invest | STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09447 | 31745030 | Indian J Med Microbiol | Gut microbiota and its mysteries. | 2020 | Details |
| A09448 | 31744629 | Environ Int | Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. | 2019 | Details |
| A09449 | 31744059 | Mar Drugs | Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice. | 2019 | Details |
| A09450 | 31744039 | J Xray Sci Technol | Quantification of hepatic steatosis in histologic images by deep learning method. | 2019 | Details |
| A09451 | 31743810 | Nutrition | Phase angle as a severity indicator for liver diseases. | 2019 | Details |
| A09452 | 31742330 | Glycobiology | Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation. | 2020 | Details |
| A09453 | 31742325 | Clin Sci (Lond) | Processes exacerbating apoptosis in non-alcoholic steatohepatitis. | 2019 | Details |
| A09455 | 31740790 | Cell Death Differ | Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. | 2019 | Details |
| A09457 | 31738141 | Curr Pharm Des | Risk of Kidney Dysfunction IN Nafld. | 2020 | Details |
| A09458 | 31737751 | Data Brief | Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. | 2019 | Details |
| A09459 | 31737583 | Can J Gastroenterol Hepatol | Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09460 | 31737175 | Oxid Med Cell Longev | Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. | 2019 | Details |
| A09461 | 31734999 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of lipolipomics in primary hepatocellular carcinoma]. | 2019 | Details |
| A09462 | 31734987 | Zhonghua Gan Zang Bing Za Zhi | [Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)]. | 2019 | Details |
| A09463 | 31734856 | Intern Emerg Med | Liver alterations in anorexia nervosa are not caused by insulin resistance. | 2019 | Details |
| A09464 | 31734449 | Clin Gastroenterol Hepatol | Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09465 | 31734402 | Autoimmun Rev | Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. | 2019 | Details |
| A09466 | 31733366 | J Pharmacol Toxicol Methods | Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models. | 2019 | Details |
| A09467 | 31733165 | Hepatology | Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up. | 2020 | Details |
| A09469 | 31731527 | Nutrients | Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study. | 2019 | Details |
| A09470 | 31731454 | Int J Mol Sci | Role of High-Mobility Group Box-1 in Liver Pathogenesis. | 2019 | Details |
| A09471 | 31731325 | Australas J Dermatol | Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: A cross-sectional cohort study. | 2019 | Details |
| A09472 | 31731192 | Biomed Pharmacother | Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. | 2019 | Details |
| A09473 | 31731005 | Contemp Clin Trials | A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial. | 2019 | Details |
| A09474 | 31730978 | Int J Biol Macromol | Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in mice. | 2019 | Details |
| A09475 | 31730885 | Toxicol Lett | In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease. | 2019 | Details |
| A09476 | 31729980 | Lipids Health Dis | FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c. | 2019 | Details |
| A09477 | 31728431 | Transl Gastroenterol Hepatol | Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. | 2019 | Details |
| A09478 | 31728429 | Transl Gastroenterol Hepatol | Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? | 2019 | Details |
| A09479 | 31728246 | Cureus | One-hour Recovery Time in Subjects Undergoing Percutaneous Liver Biopsy: A Quality Improvement and Patient Safety Project. | 2019 | Details |
| A09480 | 31728041 | Sci Rep | Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism. | 2019 | Details |
| A09481 | 31727922 | Sci Rep | Fecal microbiome signatures of pancreatic cancer patients. | 2019 | Details |
| A09482 | 31727409 | Lancet | Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. | 2019 | Details |
| A09484 | 31726978 | BMC Genomics | Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. | 2019 | Details |
| A09485 | 31726747 | Diseases | Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? | 2019 | Details |
| A09486 | 31726714 | Nutrients | Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study. | 2019 | Details |
| A09487 | 31726709 | Int J Mol Sci | A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09488 | 31726115 | J Hepatol | A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. | 2019 | Details |
| A09489 | 31725651 | Medicine (Baltimore) | Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B. | 2019 | Details |
| A09490 | 31725632 | Medicine (Baltimore) | Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study. | 2019 | Details |
| A09491 | 31724192 | Am J Hematol | Impact of natural neuromedin-B receptor variants on iron metabolism. | 2019 | Details |
| A09492 | 31724099 | Dig Dis Sci | Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients. | 2019 | Details |
| A09493 | 31723265 | Nature | Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. | 2019 | Details |
| A09494 | 31721969 | Arq Gastroenterol | IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). | 2020 | Details |
| A09495 | 31721770 | PLoS One | Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A09496 | 31720766 | Abdom Radiol (NY) | Reproducibility of hepatic MR elastography across field strengths, pulse sequences, scan intervals, and readers. | 2020 | Details |
| A09497 | 31719749 | J Toxicol Pathol | Proteomics approach to investigate dynamic protein profile involved in high fat diet-induced fatty liver disease in rats. | 2019 | Details |
| A09498 | 31718984 | J Pharm Biomed Anal | Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet. | 2019 | Details |
| A09500 | 31718031 | Cancers (Basel) | A Role for the Biological Clock in Liver Cancer. | 2019 | Details |
| A09501 | 31717994 | Nutrients | Dysregulated Iron Metabolism-Associated Dietary Pattern Predicts an Altered Body Composition and Metabolic Syndrome. | 2019 | Details |
| A09502 | 31717860 | Cells | The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression. | 2019 | Details |
| A09503 | 31717842 | Nutrients | Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09504 | 31717576 | Int J Mol Sci | The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives. | 2019 | Details |
| A09505 | 31717414 | Int J Mol Sci | Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. | 2019 | Details |
| A09506 | 31717385 | Cells | Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis. | 2019 | Details |
| A09507 | 31717358 | Nutrients | Reduced Oxidative Stress and Enhanced FGF21 Formation in Livers of Endurance-Exercised Rats with Diet-Induced NASH. | 2019 | Details |
| A09508 | 31717271 | J Clin Med | The Association between SOCS1-1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients. | 2019 | Details |
| A09509 | 31717261 | Nutrients | Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation. | 2019 | Details |
| A09510 | 31715523 | J Nutr Biochem | Interactive effects of maternal and weaning high linoleic acid intake on hepatic lipid metabolism, oxylipins profile and hepatic steatosis in offspring. | 2019 | Details |
| A09513 | 31714842 | AJR Am J Roentgenol | Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09514 | 31714387 | Eur J Gastroenterol Hepatol | Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. | 2020 | Details |
| A09515 | 31714153 | Ann Med | Impaired albumin function: a novel potential indicator for liver function damage? | 2019 | Details |
| A09516 | 31713637 | Cell Mol Life Sci | Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A09517 | 31713012 | Diabetologia | Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. | 2019 | Details |
| A09518 | 31712073 | Clin Gastroenterol Hepatol | GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09519 | 31711944 | Surg Obes Relat Dis | Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria. | 2019 | Details |
| A09521 | 31711876 | Metabolism | Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study. | 2019 | Details |
| A09522 | 31711498 | Nutr J | Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study. | 2019 | Details |
| A09523 | 31709830 | Am J Physiol Gastrointest Liver Physiol | CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. | 2019 | Details |
| A09526 | 31709254 | Front Cell Dev Biol | Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome. | 2019 | Details |
| A09527 | 31707624 | Rev Endocr Metab Disord | Dietary lipids, gut microbiota and lipid metabolism. | 2019 | Details |
| A09528 | 31706905 | J Clin Lipidol | Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug? | 2019 | Details |
| A09529 | 31706690 | Trends Endocrinol Metab | Immunoregulatory Functions of Nuclear Receptors: Mechanisms and Therapeutic Implications. | 2019 | Details |
| A09530 | 31706246 | Environ Toxicol Pharmacol | Microcystin exposure worsens nonalcoholic fatty liver disease associated ectopic glomerular toxicity via NOX-2-MIR21 axis. | 2019 | Details |
| A09531 | 31706011 | Pharmacol Res | Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism. | 2019 | Details |
| A09532 | 31705834 | Liver Int | Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes. | 2019 | Details |
| A09533 | 31705824 | Hepatology | Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population. | 2020 | Details |
| A09534 | 31705800 | Hepatology | Interleukin-22 Ameliorates Neutrophil-Driven Nonalcoholic Steatohepatitis Through Multiple Targets. | 2020 | Details |
| A09535 | 31705444 | Hepatol Int | Sarcopenia and fatty liver disease. | 2019 | Details |
| A09536 | 31705397 | J Endocrinol Invest | L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers. | 2019 | Details |
| A09537 | 31703268 | Int J Environ Res Public Health | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. | 2019 | Details |
| A09538 | 31703079 | PLoS One | Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation. | 2019 | Details |
| A09539 | 31702809 | Mol Med Rep | Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF‑κB/IκBα pathways in the skeletal muscle of rats fed with a high fat diet. | 2019 | Details |
| A09541 | 31701393 | Hepatol Int | Hepatocellular carcinoma and non-alcoholic fatty liver disease. | 2019 | Details |
| A09542 | 31701087 | Nat Metab | Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution. | 2019 | Details |
| A09543 | 31701071 | Hepatol Commun | Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein Cholesterol. | 2019 | Details |
| A09544 | 31701070 | Hepatol Commun | Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States. | 2019 | Details |
| A09545 | 31700054 | Sci Rep | Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09546 | 31699440 | Environ Int | Hepatotoxic effects of inhalation exposure to polycyclic aromatic hydrocarbons on lipid metabolism of C57BL/6 mice. | 2019 | Details |
| A09548 | 31697972 | J Hepatol | Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. | 2019 | Details |
| A09549 | 31697646 | Aging (Albany NY) | Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. | 2019 | Details |
| A09550 | 31696817 | Curr Gene Ther | Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. | 2019 | Details |
| A09551 | 31696774 | Gut Microbes | Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. | 2019 | Details |
| A09552 | 31696690 | Clin Mol Hepatol | Application of transient elastography in nonalcoholic fatty liver disease. | 2019 | Details |